SciELO - Scientific Electronic Library Online

 
vol.11 issue1Biogenesis and mechanism of action of MicroRNAs as serum biomarkers in cardiovascular diseases author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista de salud publica del Paraguay

Print version ISSN 2224-6193On-line version ISSN 2307-3349

Abstract

MONTIEL-JAROLIN, Dora Elizabeth et al. Guillain Barré syndrome associated with SARS-CoV-2 infection in a patient with a differential diagnosis of dengue. Rev. salud publica Parag. [online]. 2021, vol.11, n.1, pp.112-116. ISSN 2307-3349.  https://doi.org/10.18004/rspp.2021.junio.112.

Introduction:

Guillain-Barré syndrome has been associated with infection by the SARS-CoV-2 virus since the beginning of the pandemic.

Clinical case:

56-year-old man without comorbidity or toxic habits, consultation for a 4-day history of paresthesia in the hands and feet simultaneously, lower limb weakness, without other symptoms. The patient 22 days before, presented cough and dyspnea, 3 days of evolution, the nasopharyngeal swab for SARS-CoV-2 was positive, with outpatient treatment. He was referred to dengue in december 2019. Physical examination: Blood pressure 140/80 mmHg, heart rate 114 per minute, temperature 36 degrees, respiratory rate 20 per minute. Neurological examination: lucid patient, decreased muscular strength of the lower limbs 4/5, absent osteotendinous reflexes in four limbs, without sensory level or sphincter involvement, negative Babinski sign, absent meningeal signs. Rest of the physical examination without valuable data. Laboratory tests: white blood cells 11.5 x 10 9 / L, neutrophils: 74%, lymphocytes: 18%. Erythrosedimentation 14 mm, glycemia 99 mg / dL urea: 19 mg / dl, creatinine: 0.7 mg / dL, arterial gas: pH: 7.39, pco2: 27, pO2: 76, EB: - 7.6, HCO3 16 SO2: 96 , D-dimer 489 ng / ml. Elisa serology: HIV: negative, IGM serology negative: herpes simplex, cytomegalovirus, dengue antigen NS1: negative; dengue IgG and IgM serology: positive (November 2020, immunochromatographic test, SD, Korea), (SARS-CoV-2 IgG / IgM positive, Zika and chikungunya negative). Antinuclear antibody (ANA): 1/80, anti deoxyribonuclease (anti DNA): negative, serology negative (anti proteinase 3 / myeloperoxidase, extractable antigen from the nucleus) Cerebrospinal fluid: (CSF): (glycorrhachia) : 63 mg / dL protein: 88 mg / dL leukocytes: 2 cells / μl). PCR in CSF for SARS-CoV-2 virus was not performed. Electromyography: Findings suggestive of demyelinating polyradiculoneuropathy. Chest CT scan: pattern in bilateral patched ground glass He was treated with intravenous immunoglobulin with complete recovery of muscle strength.

Discussion:

GBS appeared on day 22 of the COVID-19 disease, there is a temporal relationship, it responds to post-infectious model and the pathogenesis would be autoimmune in nature

Keywords : COVID-19; Guillain-Barré syndrome; SARS-CoV-2; dengue.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )